Three weeks versus One week radiotherapy regimens in breast cancer patients.

Comparative evaluation of three-weeks versus one week-adjuvant postoperative radiotherapy regimens in breast cancer patients using intensity modulated radiotherapy technique : A randomized controlled study. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080216

Enrollment

Registered

2025-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Arm B: Patients will be given 26Gy in 5 fractions in 1 week. Intervention2: Arm A: Patients will be given 40Gy in 15 fractions in 3 weeks Intervention3: Arm B: Patients will be given 26

Eligibility

Inclusion criteria

Inclusion criteria: All biopsy proven post-operative early and locally advanced invasive carcinoma breast patients.

Exclusion criteria

Exclusion criteria: Stage 4 disease Metastatic carcinoma breast Pregnancy and lactation Bilateral breast tumours Contraindication to radiotherapy eg: collagen vascular disorders History of prior radiation therapy to chest wall

Design outcomes

Primary

Measure	Time frame
Primary end point is ipsilateral breast tumour relapseTimepoint: Patients will be assessed clinically for loco-regional control rate at the end of treatment , 3 months and 6 months after completion of treatment.	—

Secondary

Measure	Time frame
Acute and Sub-acute toxicities and loss of patient compliance .Timepoint: Toxicity assesment will be done weekly during treatment and at 2 weeks and 4 weeks after treatment.	—

Countries

India

Contacts

Public ContactDr Sapna Marcus Bhatty

All India Institute Of Medical sciences

sapnamarcus@gmail.com9478280097

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026